Senti Biosciences, Inc. Sustainability Profile
Senti Biosciences, Inc., a pioneering entity in the synthetic biology sector, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a leader in developing advanced gene circuits and cell therapies, focusing on innovative solutions for complex diseases. Senti's core offerings include engineered cell therapies that leverage cutting-edge synthetic biology techniques, setting them apart in a competitive market. The company’s unique approach to programmable cell therapies has garnered attention for its potential to revolutionise treatment paradigms in oncology and other therapeutic areas. With a strong emphasis on research and development, Senti Biosciences has achieved significant milestones, positioning itself as a notable player in the biotechnology landscape. Its commitment to advancing the field of synthetic biology continues to drive its growth and influence within the industry.
DitchCarbon Score
How does Senti Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Senti Biosciences, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Senti Biosciences, Inc.'s reported carbon emissions
Senti Biosciences, Inc., headquartered in the US, currently does not report any carbon emissions data, as there are no available figures for their greenhouse gas emissions in kg CO2e. Additionally, the company has not established specific reduction targets or initiatives related to climate commitments. Without emissions data or defined climate strategies, it is unclear how Senti Biosciences is addressing its environmental impact. As the industry increasingly prioritises sustainability, it will be essential for Senti Biosciences to develop and communicate its climate commitments to align with broader environmental goals.
How Carbon Intensive is Senti Biosciences, Inc.'s Industry?
How Carbon Intensive is Senti Biosciences, Inc.'s Location?
Senti Biosciences, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Senti Biosciences, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
